L
Life Biosciences
working on different ways to tackle age-related diseases with a view to ultimately extending healthy life spans
About Life Biosciences
Life Biosciences is a biotechnology startup that focuses on developing innovative therapies to treat diseases by targeting the biology of aging. The company operates in the healthcare sector, specifically in the field of biotechnology and pharmaceuticals. Their primary clients are patients suffering from age-related diseases, which currently have limited or no therapeutic options.
Read full description
The company's business model revolves around the development and commercialization of innovative therapeutics. They aim to redefine aging by developing therapies that can prevent, treat, and reverse age-related diseases. Their approach is based on groundbreaking research that suggests aging is modifiable and caused by a specific number of biological mechanisms that can be therapeutically targeted.
Life Biosciences makes money by developing these therapies and bringing them to market. The company collaborates with world-leading researchers to develop their platforms, ensuring they are based on the latest and most advanced scientific findings. Once a therapy is developed, it is tested, approved, and then sold to patients or healthcare providers.
In summary, Life Biosciences is a pioneering biotech company that aims to transform the treatment of age-related diseases by targeting the biology of aging. Their innovative approach could potentially revolutionize the healthcare sector and provide new therapeutic options for patients.
At a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Boston, United States
- Employees
- 26
- Open positions
- None listed
- Dealroom signal
- 80.4/100
- Industry
- Health, Semiconductors
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, Longevity, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Life Biosciences.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Apr 2026 | $80M | $320M | Undisclosed | ↗ |
| SERIES COther financing | Jan 2022 | $82M | $328M | Alpha Wave Ventures | ↗ |
Growth signals
Latest recorded traffic for Life Biosciences is 41K monthly website visits, up 28.1% over the last three months. Life Biosciences's team grew 8.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
- AVAlpha Wave Ventures
Other known investors2 additional known investors
Harvard Medical School
Harvard University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Life Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Life Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.